Risk of Acute Kidney Injury with concomitant use of Fluoroquinolones and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers - SAHPRA

Risk of Acute Kidney Injury with concomitant use of Fluoroquinolones and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers

Risk of Acute Kidney Injury with concomitant use of Fluoroquinolones and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers

2019 Jun

Download latest version
Document Number: DHCPL
Version: 1
Date Updated: 13/06/2019
File Type: pdf
Category: Communication To Health Care Professionals
Unit: Pharmacovigilance